TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/23 09:03 | 8/9/23 | IOBT | Io Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivo Capital Ix, LLC | CA | T | P.d | 6,000 | 1.90 | 0 | 3,158 | 105 | 6,173 | I | |||||||||||||||
11/12/21 16:16 | 11/9/21 | IOBT | Io Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivo Capital Ix, LLC | CA | T | P.d | 9,100 | 14.00 | 0 | 650 | 27 | 3,016 | D | |||||||||||||||
3/25/21 17:32 | 3/23/21 | TIL | Instil Bio, Inc. | Health | BioPrd | Biological Products, (No Diag | Vivo Capital Ix, LLC | CA | T | P.d | 6,000 | 20.00 | 0 | 300 | 2 | 12,487 | D | ||||||||||||||||
10/20/20 19:58 | 10/20/20 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vivo Capital Ix, LLC | CA | T | P.d | 4,000 | 16.00 | 0 | 250 | 8 | 3,245 | D | |||||||||||||||
7/21/20 20:25 | 7/21/20 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Vivo Capital Ix, LLC | CA | T | P.d | 18,525 | 19.00 | 0 | 975 | 186 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |